Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies—Current Research and Clinical Approaches

Multiple myeloma (MM) accounts for 10% of all hematological malignancies, and it is the second most common hematological neoplasm for which chemotherapy is an important pharmacological treatment. High dose melphalan followed by autologous stem cell transplantation remains the standard of treatment f...

Descripción completa

Detalles Bibliográficos
Autores principales: Poczta, Anastazja, Rogalska, Aneta, Marczak, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123041/
https://www.ncbi.nlm.nih.gov/pubmed/33922721
http://dx.doi.org/10.3390/jcm10091841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123041/
https://www.ncbi.nlm.nih.gov/pubmed/33922721
http://dx.doi.org/10.3390/jcm10091841

Ejemplares similares